Evolutionary Genomics, Inc. Auditor Raises 'Going Concern' Doubt
March 30, 2020
Share
Evolutionary Genomics, Inc. filed its 10-K on Mar 30, 2020 for the period ending Dec 31, 2019. In this report its auditor, Plante & Moran, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Evolutionary Genomics, Inc. is a genomics research and development company. The Company is focused on the identification and validation of genes that impact commercially traits in crops for the agriculture industry. It uses the Adapted Traits Platform (ATP) to identify commercially valuable genes that control important traits in animals and plants. Its platform identifies genes that have changed successfully to impart new or improved traits. The Company has applied its ATP in research projects, including identifying genes responsible for increases in yield in corn, increases in yield in rice, drought tolerance and sugar content in tomatoes and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The Company uses ATP to perform throughput molecular evolution analysis to identify positively selected genes based on non-synonymous site (Ka) and synonymous site (Ks) analysis.